Moreover, blood-derived tumor-specific CD8+ T cells had a considerably lower PD1 per cell expression than TILs (Fig. 7b, Supplementary Fig 13b) and also were less apoptosis-prone than tumor-derived tet+ CD8+ T cells (Fig. 7c and Supplementary Fig. 13c). The gene discussed is CD8A; the disease is neoplasm.